Author

Juan E. Diaz

Observed names: Díaz, Juan Esteban, Juan Diaz, Juan E Diaz

Institutions: Federación de Aseguradores Colombianos, Xencor (United States)

Observed institutions: University of California, San Francisco, University of California, Irvine, Federación de Aseguradores Colombianos, Xencor (United States)

ORCID: 0009-0005-3907-5338

Observed ORCID: 0009-0005-3907-5338

OpenAlex ID: A5109947122

Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins

2018 · Alexander J Martinko, Charles Truillet, et al. · eLife · 84

A robust heterodimeric Fc platform engineered for efficient development of bispecific antibodies of multiple formats

2018 · Gregory L. Moore, Matthew J. Bernett, et al. · Methods · 74

PDF

Computational design and selections for an engineered, thermostable terpene synthase

2011 · Juan E. Diaz, Chun‐Shi Lin, et al. · Protein Science · 65

PDF

Virus–Polymer Hybrid Nanowires Tailored to Detect Prostate-Specific Membrane Antigen

2012 · Jessica A. Arter, Juan E. Diaz, et al. · Analytical Chemistry · 54

Covalent Virus Layer for Mass-Based Biosensing

2008 · Li-Mei C. Yang, Juan E. Diaz, et al. · Analytical Chemistry · 46

Direct Electrical Transduction of Antibody Binding to a Covalent Virus Layer Using Electrochemical Impedance

2008 · Li-Mei C. Yang, Juan E. Diaz, et al. · Analytical Chemistry · 39

A B7-H3–Targeted CD28 Bispecific Antibody Enhances the Activity of Anti–PD-1 and CD3 T-cell Engager Immunotherapies

2024 · Gregory L. Moore, Veronica G. Zeng, et al. · Molecular Cancer Therapeutics · 21

PDF

A Split-Abl Kinase for Direct Activation in Cells

2017 · Juan E. Diaz, Charles W. Morgan, et al. · Cell chemical biology · 19

PDF

Synthesis of a Virus Electrode for Measurement of Prostate Specific Membrane Antigen

2009 · Juan E. Diaz, Li-Mei C. Yang, et al. · Methods in molecular biology · 10

Abstract 1860: Bispecific claudin-6 x CD3 antibodies in a 2 + 1 format demonstrate selectivity and activity on human ovarian cancer cells

2021 · Matthew S. Faber, Sung-Hyung Lee, et al. · Cancer Research · 8

Exploring Biochemistry and Cellular Biology with Protein Libraries

2003 · Juan E Diaz, Brett E Howard, et al. · Current Issues in Molecular Biology · 8

PDF

Engineered cellular gene-replacement platform for selective and inducible proteolytic profiling

2015 · Charles W. Morgan, Juan E. Diaz, et al. · Proceedings of the National Academy of Sciences · 7

697 Tumor-targeted CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors

2020 · Michael Hedvat, Veronica Zeng, et al. · Journal for ImmunoTherapy of Cancer · 2

PDF

Abstract 2983: Tumor-specific CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors

2023 · Matthew A. Dragovich, Viralkumar Davra, et al. · Cancer Research · 1

698 PD-L1 targeted CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors

2021 · Veronica Zeng, Gregory Moore, et al. · Journal for ImmunoTherapy of Cancer · 1

PDF

Abstract 1880: PDL1-targeted CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors

2021 · Gregory L. Moore, Veronica Zeng, et al. · Cancer Research · 1

1074 A CD2 co-stimulatory platform enhances T cell engager potency across multiple tumor targets without non-specific T cell activation

2026 · Tian Zhang, Alex Nisthal, et al. · Journal for ImmunoTherapy of Cancer

PDF

El director de orquesta de la infraestructura

2026 · Díaz, Juan Esteban · Revista Fasecolda

PDF

Figure 3 from A B7-H3–Targeted CD28 Bispecific Antibody Enhances the Activity of Anti–PD-1 and CD3 T-cell Engager Immunotherapies